mortality/aging
immune system
• hyperresponsive to imiquimod induced splenocyte proliferation
|
• detected in 8 of 8 mice
|
• greater than 10% CD11c+ cells in the blood of all mice
|
• at 2 - 3 months of age
|
• increase in the B220lo CD138+ population of B cells
|
• show spontaneous activation
|
• show spontaneous activation
|
• autoantibodies show a nuclear, nucleolar or mixed pattern
|
• increase in anti-RNA IgG levels in 8 of 9 mice
|
• detected in 3 of 8 mice
|
• detected in 6 of 8 mice
|
• detected in 2 of 8 mice
|
hematopoietic system
• hyperresponsive to imiquimod induced splenocyte proliferation
|
• detected in 8 of 8 mice
|
• greater than 10% CD11c+ cells in the blood of all mice
|
• at 2 - 3 months of age
|
• increase in the B220lo CD138+ population of B cells
|
• show spontaneous activation
|
• show spontaneous activation
|
liver/biliary system
• detected in 3 of 8 mice
|
renal/urinary system
• detected in 6 of 8 mice
|
cellular
• hyperresponsive to imiquimod induced splenocyte proliferation
|
respiratory system
• detected in 2 of 8 mice
|
growth/size/body
• detected in 8 of 8 mice
|